External quality assessment of orthohantavirus and lymphocytic choriomeningitis virus molecular detection and serology in Europe, 2021
Authors:
- Mert ErdinMEMert Erdin
- Kamelia R StanoevaKSKamelia R Stanoeva
- Ramona MöglingRMRamona Mögling
- Miša KorvaMKMiša Korva
- Nataša KnapNKNataša Knap
- Katarina Resman RusKRKatarina Resman Rus
- Cristina DomingoCDCristina Domingo
- Johan Hj ReimerinkJRJohan Hj Reimerink
- Ankje de VriesAVAnkje de Vries
- Hussein AlburkatHAHussein Alburkat
- Mira UtriainenMUMira Utriainen
- Céline M GossnerCGCéline M Gossner
Open Access
- 5 October 2023
- journal article
- research article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 28 (40) , 2300054
Abstract
Background: Rodent-borne viruses such as orthohantaviruses and arenaviruses cause considerable disease burden with regional and temporal differences in incidence and clinical awareness. Therefore, it is important to regularly evaluate laboratory diagnostic capabilities, e.g. by external quality assessments (EQA). Aim: We wished to evaluate the performance and diagnostic capability of European expert laboratories to detect orthohantaviruses and lymphocytic choriomeningitis virus (LCMV) and human antibody response towards orthohantaviruses. Methods: We conducted an EQA in 2021; molecular panels consisted of 12 samples, including different orthohantaviruses (Seoul, Dobrava-Belgrade (DOBV), Puumala (PUUV) and Hantaan orthohantavirus), LCMV and negative controls. Serological panels consisted of six human serum samples reactive to PUUV, DOBV or negative to orthohantaviruses. The EQA was sent to 25 laboratories in 20 countries. Results: The accuracy of molecular detection of orthohantaviruses varied (50‒67%, average 62%) among 16 participating laboratories, while LCMV samples were successfully detected in all 11 participating laboratories (91-100%, average 96%). The accuracy of serological diagnosis of acute and past orthohantavirus infections was on average 95% among 20 participating laboratories and 82% in 19 laboratories, respectively. A variety of methods was used, with predominance of in-house assays for molecular tests, and commercial assays for serological ones. Conclusion: Serology, the most common tool to diagnose acute orthohantavirus infections, had a high accuracy in this EQA. The molecular detection of orthohantaviruses needs improvement while LCMV detection (performed in fewer laboratories) had 95% accuracy. Further EQAs are recommended to be performed periodically to monitor improvements and challenges in the diagnostics of rodent–borne diseases.Keywords
This publication has 24 references indexed in Scilit:
- Second External Quality Assurance Study for the Serological Diagnosis of Hantaviruses in EuropePLOS Neglected Tropical Diseases, 2012
- Lymphocytic Choriomeningitis with Severe Manifestations, Missouri, USAEmerging Infectious Diseases, 2011
- Analytical validation of a lymphocytic choriomeningitis virus real-time RT-PCR assayJournal of Virological Methods, 2011
- Novel Arenavirus Sequences in Hylomyscus sp. and Mus (Nannomys) setulosus from Côte d'Ivoire: Implications for Evolution of Arenaviruses in AfricaPLOS ONE, 2011
- Detection and Typing of Human Pathogenic Hantaviruses by Real-Time Reverse Transcription-PCR and PyrosequencingClinical Chemistry, 2007
- Hantavirus in African Wood Mouse, GuineaEmerging Infectious Diseases, 2006
- Identification of Dobrava, Hantaan, Seoul, and Puumala viruses by one-step real-time RT-PCRJournal of Virological Methods, 2005
- Identification of Genetic Evidence for Dobrava Virus Spillover in Rodents by Nested Reverse Transcription (RT)-PCR and TaqMan RT-PCRJournal of Clinical Microbiology, 2005
- Hemorrhagic Fever with Renal Syndrome in the Dolenjska Region of Slovenia– A 10‐Year SurveyClinical Infectious Diseases, 1999
- Phylogenetic Analysis of theArenaviridae:Patterns of Virus Evolution and Evidence for Cospeciation between Arenaviruses and Their Rodent HostsMolecular Phylogenetics and Evolution, 1997